Last reviewed · How we verify
Quality of Life Assessed With the PAH SYMPACT Questionnaire
Researchers are evaluating quality of life in pulmonary hypertension subjects using the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire and assessing the questionnaires' performance with regard to relationship to other markers of disease severity, response to treatment, and outcome in a clinical practice setting.
Details
| Lead sponsor | Mayo Clinic |
|---|---|
| Status | COMPLETED |
| Enrolment | 390 |
| Start date | Wed Mar 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pulmonary Hypertension
Countries
United States